LEERINK PARTNERS
Leerink Partners is a leading investment bank, specializing in healthcare. Their knowledge, experience and focus enable us to help their clients define and achieve their strategic, capital markets and investment objectives. They partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare.
LEERINK PARTNERS
Industry:
Banking Health Care
Founded:
1995-01-01
Status:
Active
Contact:
(800) 808-7525
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SSL By Default Font Awesome Apache ReCAPTCHA Microsoft GoDaddy SSL Gravity Forms IIS 8 ASP.NET Ajax Google Maps For Work
Similar Organizations
Accelerator Group
Accelerator Group is an investment banking Advisory services and Knowledge Services firm.
Macquarie Group
Macquarie Group is a global provider of banking, financial, advisory, investment and funds management services.
Moda Health
Moda Health offers quality health coverage in Oregon, Washington, and Alaska.
Current Advisors List
Current Employees Featured
Founder
Investors List
Lovell Minnick Partners
Lovell Minnick Partners investment in Private Equity Round - Leerink Partners
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-08-26 | Kinnate Biopharma | Leerink Partners investment in Series C - Kinnate Biopharma | 98 M USD |
2019-05-23 | AlloVir | Leerink Partners investment in Series B - AlloVir | 120 M USD |
2018-09-05 | Fulcrum Therapeutics | Leerink Partners investment in Series B - Fulcrum Therapeutics | 80 M USD |
2018-06-08 | Precision BioSciences | Leerink Partners investment in Series B - Precision BioSciences | 110 M USD |
2018-05-16 | FogPharma | Leerink Partners investment in Series B - FogPharma | 66 M USD |
2018-02-27 | Generation Bio | Leerink Partners investment in Series B - Generation Bio | 100 M USD |
2018-02-01 | Avrobio | Leerink Partners investment in Series B - Avrobio | 60 M USD |
2017-11-13 | Arcus Biosciences | Leerink Partners investment in Series C - Arcus Biosciences | 107 M USD |
2017-09-08 | Replimune Group | Leerink Partners investment in Series B - Replimune Group | 55 M USD |
2017-03-30 | Solid Biosciences | Leerink Partners investment in Series C - Solid Biosciences | 50 M USD |
Newest Events participated
Key Employee Changes
Date | New article |
---|---|
2021-10-14 | Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer |
More informations about "Leerink Partners" on Search Engine
Leerink Partners - Wikipedia
Leerink Partners LLC is an independent investment bank providing healthcare companies and investors with financial services including M&A advisory, equity and debt capital markets, proprietary research, and sales and trading capabilities. The firm was founded in 1995 by Jeffrey A. Leerink, and is headquartered in Boston, with offices in New York City, San Francisco, Charlotte, โฆSee details»
about | Leerink Partners
Sep 24, 2019 Leerink Partners. Helping our clients move healthcare forward. Search. Sectors. Biopharma. Digital Health & HealthTech. Healthcare Services. Medical โฆSee details»
Leerink Partners | LinkedIn
Leerink Partners | 16,433 followers on LinkedIn. Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, โฆSee details»
Leerink Partners - Crunchbase Investor Profile & Investments
Leerink Partners is a leading investment bank, specializing in healthcare. Their knowledge, experience and focus enable us to help their clients define and achieve their strategic, โฆSee details»
Leerink Partners Successfully Completes Management Buy-Out
Oct 2, 2023 Leerink Partners stands at the forefront of the healthcare investment banking industry and excels in delivering bespoke financial solutions, M&A expertise, and โฆSee details»
Leerink Partners - Funding, Financials, Valuation & Investors
May 22, 2006 Investors 1. Funds 2. Funding. Leerink Partners has raised 1 round. This was a Private Equity round raised on May 22, 2006. Leerink Partners is funded by Lovell โฆSee details»
Leerink Partners - Contacts, Employees, Board Members, โฆ
Leerink Partners. Connect to CRM. Summary Financials Investments People Technology Signals & News Similar Companies. Highlights. Employee Profiles 6. Number of Board โฆSee details»
SVB Securities returns to Leerink Partners name following $100M โฆ
Jul 6, 2023 The investment bank will begin doing business again as Leerink Partners, the organization announced Thursday. The management buyout is backed by the Baupost โฆSee details»
Leerink Partners | The Org
Leerink Partners. 0 followers. Follow. Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, โฆSee details»
Steward Health Explores Sale of Managed Services Organization
Mar 25, 2024 Bloomberg News. Steward Health Care has engaged Leerink Partners to explore a possible sale of the hospital operatorโs managed services organization, โฆSee details»
Firm | Leerink Partners - SVB Securities
Leerink Partners. Helping our clients move healthcare forward. Search. Sectors. Biopharma. Digital Health & HealthTech. Healthcare Services. Medical Technology. Tools & โฆSee details»
Leerink Partners Announces Expansion with New Los Angeles โฆ
23 hours ago This new location follows the recently opened Miami office in December 2023. To lead the firm's strategic expansion in Los Angeles, Leerink Partners also โฆSee details»
Leerink Partners Announces Expansion with New Los Angeles โฆ
10 hours ago Leerink Partners. Contact: Diane Vieira. (617) 918-4097. Prosek Partners for Leerink Partners. Contact: Michael Schutsky. (646) 818-9251. SOURCE Leerink โฆSee details»
enGene To Present at the Leerink Partners Global Biopharma
Mar 5, 2024 enGene is a clinical-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, with โฆSee details»
Leerink Partners - Investments, Portfolio & Company Exits
About. Leerink Partners has made 17 investments. Their most recent investment was on Dec 5, 2023, when Odyssey Therapeutics raised. $101M. Leerink Partners has made 9 โฆSee details»
Leerink Partners Announces Expansion with New Los Angeles โฆ
10 hours ago Leerink Partners Contact: Diane Vieira (617) 918-4097. ... Curia, a leading contract research, development and manufacturing organization and Carterra Inc., the โฆSee details»
Leerink Partners Announces Expansion with New Los Angeles โฆ
23 hours ago May 9, 2024. Leerink Partners, a leading investment bank specializing in healthcare, today announced the opening of a new office in Los Angeles to cement its โฆSee details»
News | Leerink Partners - SVB Securities
News | Deal Announcement. Leerink Partners Serves as Exclusive Financial Advisor for SQZ Biotechnologiesโ Asset Sale to STEMCELL Technologies. December 2023. News | โฆSee details»
SVB Financial seeks to sell venture capital arm
6 days ago The buyer is a newly created entity with ties to Pinegrove Capital Partners, a Los Angeles venture capital firm. Silicon Valley Bank said it plans to sell off its venture โฆSee details»
Q1 2024 Karyopharm Therapeutics Inc Earnings Call - Yahoo โฆ
20 hours ago Jonathan Chang; Analyst; Leerink Partners. Presentation. Operator. Good morning. My name is Liz, and I'll be your conference operator today. At this time, I'd like โฆSee details»